
    
      This study aims to evaluate the sensitivity of the following novel assays for evaluation of
      HBV infection and assessment of treatment eligibility;

        -  GeneXpert HBV DNA via Fingerstick testing,

        -  Dried Blood Spot based HBV DNA

        -  Point of care ALT.
    
  